Purchases and Sales Made in Q3 2022 in Innate Pharma Sa (IPHA)
This table provides information about the institutional ownership of Innate Pharma Sa (IPHA) during Q3 2022. The information is specifically focused on institutions that hold shares of Innate Pharma SA.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Balyasny Asset Management LLC
Chicago, IL |
BUY
|
- |
16.1KNew |
$32.2K - $51.5K
|
16.1K
$28.5K
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
10.3K+ 22.01% |
$20.5K - $32.8K
|
56.9K
$101K
|
|
|
Nov 14, 2022
Q3 2022
|
Optiver Holding B.V.
Amsterdam, P7 |
BUY
|
- |
3.37K+ 1.85% |
$6.73K - $10.8K
|
185K
$328K
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
1.55K+ 52.4% |
$3.1K - $4.96K
|
4.51K
$7.97K
|
|
|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
177New |
$354 - $566
|
177
$313
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 10, 2022
Q3 2022
|
Citigroup Inc
|
SELL
|
- |
-1- 1.82% |
$2 - $3.2
|
54
$95.6
|
|
|
Nov 03, 2022
Q3 2022
|
Barclays PLC
London, X0 |
SELL
|
- |
-2.06K- 94.36% |
$4.11K - $6.58K
|
123
$218
|
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-2.22K- 13.18% |
$4.44K - $7.11K
|
14.6K
$25.9K
|
|
|
Nov 14, 2022
Q3 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-6.5K- 25.7% |
$13K - $20.8K
|
18.8K
$33.3K
|
|
|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-10.5K- 5.96% |
$20.9K - $33.4K
|
165K
$292K
|
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-14.6K- 2.94% |
$29.3K - $46.8K
|
483K
$854K
|